Company news
Docmorris Ltd (SIX:DOCM) news
Every Docmorris Ltd press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Online pharmacy DocMorris launches AI-driven cost-savings programme, cuts 100 jobs
June 25, 2026
Stiftung Warentest tests online pharmacies: DocMorris comes out on top
May 27, 2026
2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
May 12, 2026
Shareholder CEPD Says It Rejects DocMorris' Mischaracterisation And Emphasizes Case For Real Governance Reform
April 16, 2026
DocMorris enhances its leading AI-powered health platform by partnering with Hello Inside to address metabolic healthcare
April 14, 2026
CEPD N.V Proposes To AGM Of DocMorris Major Renewal Of Board Of Directors
March 25, 2026
DOCM: Strong Rx and digital growth, margin expansion, and Google partnership set up 2026 EBITDA breakeven
March 19, 2026
DocMorris AG announces changes to its Board of Directors
March 3, 2026
DocMorris receives TÜV certification for temperature-controlled delivery of pharmaceuticals
February 20, 2026
DocMorris and Infermedica simplify health: from symptoms to solutions with the AI health companion
February 12, 2026
Swiss stocks - Factors to watch on February 3
February 3, 2026
Docmorris Redeems Convertible Bonds Due 2026
February 2, 2026
DocMorris Repurchases Convertible Bonds Maturing In 2026 Worth Around Chf 14.4 Mln
January 27, 2026
DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
January 26, 2026
Swiss online pharmacy DocMorris 2025 revenue meets growth targets
January 20, 2026
Swiss stocks - Factors to watch on November 14
November 14, 2025
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
November 13, 2025
Docmorris AG Convertible And Delta Placing Final Delta Size Was C. 1.2m Shs / C. CHF 6.6m, Says Bookrunner
October 22, 2025
Bookrunner Says DocMorris AG Delta Placing Orders Below CHF 5.45 Per Share Risk Missing
October 21, 2025
Docmorris AG - Docmorris Increased Its External Revenue[1] By 9.5 Per Cent[2] To CHF 854.3 Million In First Nine Months 2025
October 16, 2025
DOCM: Rx and TeleClinic growth, margin gains, and robust funding support a positive 2025 outlook
August 19, 2025
DocMorris AG: Federal Court of Justice confirms admissibility of prescription bonuses
July 17, 2025
gematik extends DocMorris CardLink approval until January 2027
July 15, 2025
Baader Helvea cuts Docmorris to 'reduce', awaits capital increase amid weaker guidance
April 17, 2025
Aixtron, Bayer, Cerillion
April 15, 2025
DOCM: Strong Rx and TeleClinic growth, fully underwritten CHF 200m raise, EBITDA break-even in 2026
April 10, 2025
DOCM: Revenue up 7%, non-Rx profitable, Teleclinic doubled, CHF 200M raise planned for Rx growth
March 13, 2025
DOCM: E-prescription momentum drove double-digit Rx growth and record customer gains in Q3
October 15, 2024
DOCM: CardLink-fueled eRX growth and TeleClinic gains drive recovery, with 2024 revenue up 5–10%
August 20, 2024